• Home
• About
• Pipeline
• Our Team
• Investors
• Newsroom

Newsroom

• Press Releases
  • Current
  • 2013 Archive
  • 2012 Archive
  • 2011 Archive
  • 2010 Archive
  • 2009 Archive
  • 2008 Archive
  • 2007 Archive
  • 2006 Archive
  • Media Coverage »

Kythera Newsroom

2010 Archive

October 27, 2010
Kythera Appoints François Kress To Board Of Directors

September 21, 2010
Kythera Biopharmaceuticals Announces Completion of Proof of Concept Study for ATX-104, a Light-Activated Facial Contouring Agent

September 20, 2010
Kythera Biopharmaceuticals to Present at the UBS 2010 Global Life Sciences Conference

September 20, 2010
Kythera Biopharmaceuticals Announces Proof-of-Concept Study Results for ATX-202 In Vitiligo; Plans to Continue Research Efforts In Pigmentation Disorders

August 30, 2010
Kythera and Bayer Dermatology Unit Intendis Enter Licensing and Development Agreement for Adipolytic Agent ATX-101

June 11, 2010
Kythera Biopharmaceuticals to Participate in The Private Company Forum at The 31st Annual Goldman Sachs Global Healthcare Conference

April 27, 2010
Kythera Biopharmaceuticals Appoints Industry Veteran as Vice President, Global Clinical Operations

January 8, 2010
KYTHERA Biopharmaceuticals To Present At The 28th Annual J.P. Morgan Healthcare Conference